Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Dexcom (DXCM)

Dexcom (DXCM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 49,852,912
  • Shares Outstanding, K 96,706
  • Annual Sales, $ 1,927 M
  • Annual Income, $ 493,600 K
  • 60-Month Beta 0.79
  • Price/Sales 22.89
  • Price/Cash Flow 118.49
  • Price/Book 23.17
Trade DXCM with:

Options Overview

Details
  • Implied Volatility 31.60%
  • Historical Volatility 48.58%
  • IV Percentile 1%
  • IV Rank 4.46%
  • IV High 65.22% on 10/20/20
  • IV Low 30.03% on 06/15/21
  • Put/Call Vol Ratio 1.31
  • Today's Volume 759
  • Volume Avg (30-Day) 1,466
  • Put/Call OI Ratio 0.79
  • Today's Open Interest 43,831
  • Open Int (30-Day) 42,253

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.61
  • Number of Estimates 10
  • High Estimate 0.71
  • Low Estimate 0.48
  • Prior Year 0.94
  • Growth Rate Est. (year over year) -35.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
428.13 +20.18%
on 07/06/21
527.10 -2.38%
on 08/04/21
+82.94 (+19.22%)
since 07/02/21
3-Month
318.45 +61.57%
on 05/13/21
527.10 -2.38%
on 08/04/21
+143.11 (+38.53%)
since 05/04/21
52-Week
305.63 +68.35%
on 11/02/20
527.10 -2.38%
on 08/04/21
+72.64 (+16.44%)
since 08/04/20

Most Recent Stories

More News
Stock Market News for Aug 2, 2021

Benchmarks closed in the red on Friday, with renewed concerns revolving around the increase in coronavirus cases especially due to delta variant and a disappointing Q2 earnings report from Amazon.

BA : 226.63 (-1.07%)
AMZN : 3,354.72 (-0.34%)
MSFT : 286.51 (-0.21%)
CVX : 100.30 (-2.24%)
CAT : 204.52 (-1.91%)
XOM : 56.84 (-2.34%)
EBAY : 68.00 (-0.01%)
DXCM : 514.53 (-1.28%)
DIS : 172.58 (-0.24%)
FB : 358.92 (+2.19%)
TEAM : 340.44 (+3.35%)
Stocks Retreat as a Plunge in Amazon Fuels Growth Concerns for Big-Tech Companies

The S&P 500 Index ($SPX ) on Friday closed down -0.54%, the Dow Jones Industrials Index ($DOWI ) closed down -0.42%, and the Nasdaq 100 Index ($IUXX ) closed down -0.59%. U.S. stock indexes on Friday...

$SPX : 4,402.66 (-0.46%)
$DOWI : 34,792.67 (-0.92%)
$IUXX : 15,083.39 (+0.15%)
ZNU21 : 134-230 (unch)
NWL : 24.83 (-1.55%)
AMZN : 3,354.72 (-0.34%)
EBAY : 68.00 (-0.01%)
ETSY : 202.10 (+6.11%)
W : 251.05 (+0.63%)
SWKS : 186.79 (-0.74%)
DXCM : 514.53 (-1.28%)
$VIX : 17.65 (-1.78%)
DexCom (DXCM) Q2 Earnings and Revenues Surpass Estimates

DexCom's (DXCM) second-quarter results benefit from domestic and international revenue growth and solid new customer additions.

BSX : 44.26 (-2.81%)
LH : 300.08 (unch)
DXCM : 514.53 (-1.28%)
WST : 428.14 (+1.41%)
DexCom (DXCM) Beats Q2 Earnings and Revenue Estimates

DexCom (DXCM) delivered earnings and revenue surprises of 76.74% and 8.59%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

DXCM : 514.53 (-1.28%)
New Strong Sell Stocks for July 28th

AEVA, BKD, CSGS, DXCM and EIG have been added to the Zacks Rank #5 (Strong Sell) List on July 28, 2021.

DXCM : 514.53 (-1.28%)
BKD : 7.20 (-2.57%)
EIG : 40.66 (-1.93%)
CSGS : 44.47 (-0.98%)
AEVA : 8.54 (+1.43%)
DexCom (DXCM) to Report Q2 Earnings: What's in the Cards?

DexCom's (DXCM) second-quarter results are likely to reflect rising global awareness of its real-time CGM.

CERN : 80.09 (-2.22%)
DXCM : 514.53 (-1.28%)
HRC : 137.44 (-0.93%)
AVNS : 33.97 (-8.02%)
Analysts Estimate DexCom (DXCM) to Report a Decline in Earnings: What to Look Out for

DexCom (DXCM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DXCM : 514.53 (-1.28%)
Dexcom's (DXCM) Digital Network Benefits From Latest FDA Nod

Recent regulatory clearance of Dexcom's (DXCM) real-time APIs is expected to aid diabetics as well as their care providers in accessing GCM data.

GRMN : 162.28 (+0.81%)
DXCM : 514.53 (-1.28%)
VEEV : 340.98 (+0.87%)
TDOC : 149.73 (-1.11%)
FDA Clears Dexcom Real-Time APIs for Third-Party Apps and Devices

DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today U.S. Food and Drug Administration (FDA) clearance of the Dexcom Partner...

DXCM : 514.53 (-1.28%)
Is DexCom a Winning Diabetes Stock to Buy?

Continuous glucose monitoring (CGM) device maker DexCom (DXCM) has made key advancements in diabetes management technology to tap growing diabetes market opportunities. However, despite having a first-mover...

DXCM : 514.53 (-1.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes.

See More

Key Turning Points

3rd Resistance Point 537.32
2nd Resistance Point 532.21
1st Resistance Point 523.37
Last Price 514.53
1st Support Level 509.42
2nd Support Level 504.31
3rd Support Level 495.47

See More

52-Week High 527.10
Last Price 514.53
Fibonacci 61.8% 442.50
Fibonacci 50% 416.36
Fibonacci 38.2% 390.23
52-Week Low 305.63

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar